Search
for
Sort by
Research 30 of 428
- Hypertrichosis and Increased Pigmentation of Eyelashes and Adjacent Hair in the Region of the Ipsilateral Eyelids of Patients Treated with Unilateral Topical Latanoprost
- A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia
- Lack of efficacy of topical latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients with alopecia areata
- Latanoprost in the treatment of eyelash alopecia in alopecia areata universalis
- Hypertrichosis induced by latanoprost
- Lack of efficacy of topical latanoprost in the treatment of eyebrow alopecia areata
- Effect of Latanoprost on Hair Growth in the Bald Scalp of the Stump-tailed Macacque: A Pilot Study
- Latanoprost Loaded in Polymeric Nanocapsules for Effective Topical Treatment of Alopecia
- Lash Ptosis Caused by Latanoprost
- Erosive pustular dermatosis of the scalp following topical latanoprost for androgenetic alopecia
- The efficacy of latanoprost in the treatment of alopecia areata of eyelashes and eyebrows
- Efficacy of topical latanoprost versus minoxidil and betamethasone valerate on the treatment of alopecia areata
- Latanoprostene bunod ophthalmic solution 0.024% in the treatment of open-angle glaucoma: design, development, and place in therapy
- Nanostructured lipid carriers loaded with an association of minoxidil and latanoprost for targeted topical therapy of alopecia
- LC–MS bioanalytical method for simultaneous determination of latanoprost and minoxidil in the skin
- Latanoprost-induced Skin Depigmentation
- Repigmentation of hair after latanoprost therapy
- Comparison of efficacy, safety and satisfaction of latanoprost versus minoxidil, betamethasone and in combination in patients with alopecia areata: A blinded multiple group randomized controlled trial
- Hypertrichosis of the malar areas and poliosis of the eyelashes caused by latanoprost
- A Randomized, Double-Blind, Placebo-Controlled Pilot Study to Evaluate the Efficacy and Safety of Latanoprost for Eyelash Growth in Aesthetic Medicine
- The effect of latanoprost 0.005% solution in the management of scalp alopecia areata, a randomized double‐blind placebo‐controlled trial
- A randomized comparative study of the efficacy of topical latanoprost versus topical betamethasone diproprionate lotion in the treatment of localized alopecia areata
- Comparison between the effectiveness of topical Latanoprost and topical Minoxidil in treating Scalp Alopecia Areata in relation to CD8 cell expression: A study using clinical, dermoscopic, and immunohistochemical methods
- Hypertrichosis of the malar areas and poliosis of the eyelashes caused by latanoprost
- Topical latanoprost acid for female androgenetic alopecia: a pilot proof-of-concept trial with mechanistic evidence of prostaglandin F2α receptor activation
- In Vitro Evaluation of Topical Follicular Delivery of Minoxidil and Latanoprost Co-Entrapped in Lipid Nanocarriers
- Latanoprost
- Efficacy of Topical Latanoprost Versus Topical Minoxidil In the Treatment of Alopecia Areata: Clinical and Dermoscopic Study
- Nanostructured Lipid Carriers Loaded with an Association of Minoxidil and Latanoprost for Targeted Topical Therapy of Alopecia
- o POSSÍVEL USO DA LATANOPROSTA NA TERAPIA CAPILAR